Article Versions Notes

Oroujeni M, Xu T, Gagnon K, Rinne SS, Weis J, Garousi J, Andersson KG, Löfblom J, Orlova A, Tolmachev V. The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule. Pharmaceutics. 2021; 13(2):292. https://doi.org/10.3390/pharmaceutics13020292

Oroujeni, Maryam, Tianqi Xu, Katherine Gagnon, Sara S. Rinne, Jan Weis, Javad Garousi, Ken G. Andersson, John Löfblom, Anna Orlova, and Vladimir Tolmachev. 2021. "The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule" Pharmaceutics 13, no. 2: 292. https://doi.org/10.3390/pharmaceutics13020292

Oroujeni, M., Xu, T., Gagnon, K., Rinne, S. S., Weis, J., Garousi, J., Andersson, K. G., Löfblom, J., Orlova, A., & Tolmachev, V. (2021). The Use of a Non-Conventional Long-Lived Gallium Radioisotope ⁶⁶Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule. Pharmaceutics, 13(2), 292. https://doi.org/10.3390/pharmaceutics13020292